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Summary.-Single-cell suspensions prepared by enzymatic disaggregation of an
immunogenic 3-methylcholanthrene-induced sarcoma (Mc4OA) contain a significant
proportion of infiltrating leucocytes (42%) comprising T lymphocytes, macro-
phages and non-phagocytic FcR+ lymphoid-like cells. Tumour-infiltrating lympho-
cytes (TIL) were isolated and purified by successive passage over Sephadex G-10
columns and their cytotoxic activity in vitro compared with that of lymphoid cells
from normal rats and from tumour-bearers at different times after implantation.
For this purpose, surviving target cells were quantified by incorporation of the
y-emitting analogue of methionine,75Sel-methionine, in a 48-h assay which detected
both cytotoxic and cytostatic effects. The reactivity of TIL, which was consistently
demonstrable from 11 days after tumour transplantation, was essentially similar to
that ofnormal splenic lymphocytes in magnitude and specificity. Reciprocal cytotoxi-
city tests using TIL and cultured targets from an antigenically unrelated tumour of
similar aetiology (Mc57) showed that the manifestation ofTIL cytotoxicity was deter-
mined, not by the tumour of origin, but by the susceptibility of the target cells. Evi-
dence that the effector function of TIL was mediated in part by natural killer (NK)
cells was derived from concurrent experiments using human myeloid cells (K562) as
targets in an 18h 51Cr-release assay. In this system the level of NK activity was
critically dependent on the numbers oftumour cells inthe TIL population; contamina-
tion in excess of2% gave rise to dose-dependent inhibition of NK function. The results
show that within a progressively growing tumour known to possess rejection anti-
gens, NK reactivity was detected in the absence of a demonstrable tumour-specific
cytotoxic component.
SINCE the initial demonstration by Evans
(1972, 1973a) that experimental tumours
contain substantial numbers ofinfiltrating
macrophages, it has become apparent that
primary and transplanted neoplasms com-
prise a diversity of host cell types. Their
presencehas been documented byexploita-
tion of certain physical characteristics,
serological analysis and the application of
surface-marker techniques to include, pre-
dominantly, cells of the monocyte-macro-
phage series (Eccles & Alexander, 1974;
Haskill et al., 1975a; Van Loveren & Den
Otter, 1974), cells with receptors for the
third component of complement (C3) or
the Fc portion ofIgG (FcR) (Kerbel et al.,
1975; Wood et al., 1975), T cells (Russell
et al., 1976a, b; Pross & Kerbel, 1976;
Holden et al., 1976) and B cells (Pross &
Kerbel, 1976; Russell et al., 1976a, b) in
preparations derived from a variety of
chemically and virus-induced non-lymph-
oid tumours in both solid and ascitic
forms (Tracey et al., 1975; Biddison et al.,
1977).
In many of these and related studies,
cytotoxicity was attributed to theinfiltrat-
ing cells, which in some instances was
* Presenit address: Department of Bacteriology, University of Edirnburgh Medical School, Teviot Place,
Edinburgh.NK CELLS IN TUMOUR-BEARING RATS
specific for the tumours involved (Van
Loveren & Den Otter, 1974; Gillespie
et al., 1977; Haskill et al., 1975b) and in
others, non-specific (Evans, 1973b; Has-
kill et al., 1975a). In the Moloney sarcoma
virus (MSV) system, important differences
in the functional activity of host cells
infiltrating progressors and regressors have
been disclosed, with potentially important
implications for the balance ofthetumour-
host relationship (Gillespie et al., 1977;
Russell et al., 1977).
Studies on the nature of the cellular
infiltrate in a series of 5 transplanted rat
tumours revealed several features in
common with other tumour systems, in
respect of the heterogeneity of cell types
and the predominance of T lymphocytes,
macrophages and non-phagocytic lymph-
oid-like FcR+ cells (Moore & Moore,
1977a). Although the pattern was complex
in that the infiltrates varied in type and
extent as a function of tumour develop-
ment (Moore & Moore, 1977b), a clear
distinction was observed between estab-
lished immunogenic and non-immunogenic
tumours, suggesting that the character
and magnitude of the infiltrate was deter-
mined by cell-mediated responses against
tumour-rejection antigens.
Since among certain progressor neo-
plasms there is an apparent relationship
between host-cell content and the rate of
tumour growth in vivo and/or the pro-
pensity to metastasize (Wood & Gillespie,
1975; Alexander et al., 1976; Moore &
Moore, 1977b), the in-vitro interaction of
the principal infiltrating host cells with
those of the corresponding tumour has
been studied. For this purpose Mc40A, an
immunogenic chemically induced rat sar-
coma, was selected in which the host-cell
content, comprising T lymphocytes, mac-
rophages and non-phagocytic FcR+ cells
amounted to 42% ofthe total population
(Moore & Moore, 1977a). The data in this
study are confined to a comparison of
systemic and in-situ expressions of host
lymphocyte cytotoxicity; the reactivity of
intra-tumour macrophages will bereported
elsewhere.
The experimental protocol was designed
on the premise that systemic activity in
tumour bearers and that of tumour-infil-
trating lymphocytes (TIL) might consist of
at least 2 elements: a tumour-directed
component in which the predominant
effector cells are T lymphocytes and a non-
specific component where the properties
of the effector cells (natural killer, or NK
cells) are similar to those previously
described in rats (Oehler et al., 1978a) and
to which Mc4OA tumour cells are known
to be susceptible (Potter & Moore, 1978).
MATERIALS AND METHODS
Rat8.-The animals used in this study were
adult, male syngeneic rats of the Nottingham
Wistar (W/Not) strain.
Tumrours.-Mc40A was an immunogenic
fibrosarcoma induced originally by 3-methyl-
cholanthrene and maintained by serial s.c.
transplantation under ether anaesthesia.
Tumours were used between 14 and 20
generations of passage. Details of other
tumours used in thisstudy (Mc57, AAF57 and
Sp22) have been published previously (Moore
& Moore, 1977a). Tumour-infiltrating lympho-
cytes (TIL) were isolated from neoplasms
which had developed from s.c. trocar grafts
ot non-necrotic tumour tissue. Although this
procedure involved the transfer of infiltrating
host cells from donor to recipient, it was
necessitated by the fact that ' 1-5 g oftissue
tumour was required to yield 5 x 106 TIL.
Inoculation of cultured Mc4OA free of con-
taminating host cells failed to produce
tumours of sufficient size until at least Day
20, by which time the host-cell content as a
proportion of the total population was in
decline (Moore & Moore, 1977b). Logistical
considerations precluded the use of much
larger inocula which would have yielded
usable tumours in a shorter time.
Tissue culture.-Cell lines from the various
tumours were initiated and maintained as
monolayer cultures in RPMI 1640 medium
supplemented with 10% foetal bovine serum
(FBS) and antibiotics, as previously de-
scribed (Moore & Moore, 1977a).
The human myeloid cell line, K562 (a gift
of Dr Eva Klein, Karolinska Institute,
Stockholm) was maintained as a suspension
culture in the same medium.
The isolation of mycoplasma from tumour
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(ell lines was attempted by incubating ciil-
ture supernatants on Oxoid mycoplasma
agar (CM 401) in medium containing myco-
plasma agar (35 ml), horse serum (unheated,
natural clot, 20o% v/v, Wellcome Labora-
tories, Beckenham, Kent), yeast extract
(Oxoid) 5 ml, Thallous acetate (1% aqueous)
1-25 ml, and penicillin (1 mega unit) 0-1 ml.
Incubation was for 3-4 days in N2, wxhen
plates were examinaed for typical colonies.
All tests were negative.
Sephadex G-10 column preparation. Pre-
soaked Sephadex G-10 (Pharmacia Ltd) wias
washed and resuspended in an equal volume
of PBS. Aliquots of 50 ml were dispensed in
100ml bottles and sterilized by autoclaving.
Four identical columns wA-ere prepared
asceptically for each lymphocyte separation.
For this purpose, the barrels of 20ml plastic
syringes were packed with nylon fibre (Type
200, Fenwal Laboratories Ltd), previously
soaked in PBS, to the 2ml mark. Five ml of
PBS was added follow-ed by the Sephadex
G-10 slurry which wAas packed to the 16mnl
mark. After discharge ofPBS from the bottom
of the column to assist Sephadex packing,
each column was equilibrated by running
through 50 ml of Eagle's minimal essential
medium (MEM) supplemented with 10%
FPBS and buffered with 40rmM HEPES.
Prep(aration of effector cells
Tunmour-infiltratting lynmphocytes (TIL).
Minced tumour tissue was disaggregated by
stirring in 40 inl of a mixture of papain,
collagenase and DNase (PCD) for 1 h at room
temperature (Moore & Moore, 1977a,). After
sedimentation of undigested fragments for
1 min the supernatant cell suspension was
harvested, washed x 3 inMEM/10% FBS and
resuspended at 5 x 107 viable cells/ml in
MEM/10% FBS. TwNo ml of this cell suspen-
sion was applied to each of 3 Sephadex G-10
columns and allowed to slowNly run into the
top of the Sephadex. This was followed by
2 ml of MEM/10% FBS and the top 2 ml of
the Sephadex resuspended by stirring. Each
column w-as then eluted with 25 ml of MEM/
10% FBS, and the eluted cells were har-
vested, pooled, resuspended in 2 ml MEM/
10% FBS and run into the 4th Sephadex
G-10 column. This was then eluted wA-ith 10 ml
of MEM/10% FBS and the final eluted cell
suspensions incubated on a tissue culture
grade Petri dish for 1 h at 37°C. Non-adherent
cells were removed by gently washing thie
Petri dishes with streams of MEM/1000, PBS
and, after harvesting, TIL wN-ere resuspended
at 2 x 106 cells/ml in supplemented RPMI
1640 medium for cytotoxicity testing.
Differential counts wNere performed on
Jenner-Giemsa-stained cvtocentrifuge pre-
parations of TIL incubated with polystyrene
latex in the presence of 20% FBS at 37°C foi
45 min with continuous shaking.
Lymphnode and spleen cells. Both lymph-
node and spleen-cell suspensions wAere pre-
pared by gently pressing the tissues through
200-gauge stainless-steel mesh wNith a plastic
syringe plunger. Splenic erythrocytes wNere
lysed by pulse exposure to double-distilled
water and cell suspensionis were washed x 3
in Hanks' balanced salt solution (HBSS)
before resuspension in 10 ml of RPMI 1640,
follow-ed by incubation on tissue-culture
grade plastic Petri dishes for 1 h at 37°C.
Non-adherent cells were removed by gently
washing the Petri dish with streams of
medium, harvested and resuspended at the
appropriate concentration in supplemented
RPMI 1640 medium.
After erythrocyte lysis spleen cells were
also taken through the same procedure as that
used to isolate TIL fromn tumour-cell suspen-
sions. To do this the -whole operation was
scaled dowN-n by one-half. For inistance. 10ml
syringe barrels were substituted for 20ml
syringe barrels.
Antisera and rosetting technique. During
the isolation of TIL. T cells were monitored
bv indirect immunofluorescence using a
rabbit anti-rat thymocyte serum (ATS), the
properties of which have been previously
described (Moore & Moore. 1977a). FcR+ cells
Mwere determined bv formation of EA rosettes
(EA-RFC).
(ytotoxicity assays
75Selenomiethioninepost-labellinqy assay (758S_e
assay). The technique used -was essentially
that of Brooks et al. (1978) and in this assay
all manipulations of effectors and targets
wN-ere carried out in RPMI 1640 medium
supplemented w-ith 20% outbred Wistar rat
serum, unless other-wise stated. Effectors
were resuspended at a concentration of
2 x 1(6 viable cells/mnl in supplemented
RPMI 1640 medium before addition to target
cells.
Tumour-cell monolayers were suspended
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with 0.1% trypsin in HBSS, washed and re-
suspended in supplemented RPMI 1640 at a
concentration of 2 x 104 viable cells/ml.
Target-cell suspensions (01 ml) were added
to 0-3ml wells of tissue-culture grade flat-
bottomed microtest plates (Sterilin Plastics
Ltd). These were then incubated at 37°C for
, 6 h to allow tumour cells to adhere before
addition of 2 x 105 effector cells in 0 I ml of
medium. Each test was performed in quadru-
plicate.
After incubation at 37°C in an atmosphere
of 5%U C02 for 48 h, 0-15 ml of supernatant
medium was removed from each well, to
which was then added 0 05 ml of RPMI 1640
supplemented writh 20% FBS and containing
4 ,uCi/ml of 75Se methionine (Radiochemical
Centre, Amersham) and the plates incubated
for a fiurther 18 h at 37°C. At the termination
of the test non-adherent cells were carefully
flushed out of the wells and the plates subse-
quently processed for isotopic counting as
described by Brooks et al. (1978).
The relationship between the number of
cells counted microscopically immediately
after washing and radioactivity in each well
was linear for each tumour-cell line used, over
the range 103 to 2 x 104 tumour cells/well.
Long-term assays of this type measure the
sum of cytotoxic and cytostatic effects
mediated by effector-cell populations. These
effects cannot be differentiated, and for ease
of presentation the phenomenon is described
as "cytotoxicity".
All tests included control w%xells wAithout
cells, with tumour cells alone, and writh
effector cells alone. The background ct/min
of wells containing no cells was always
<0200 ofthe count oftumour cells alone and
the background count of lymphnode, TIL or
spleen cells alone wA-as routinely less than 50%.
Percentage cytotoxicity was calculated from
the following formula:
cytotoxicity= 1
Mean ct/min
Targets+effectors J
Mean ct/min
Tumour cells alone
Mean ct/min
Effectors alone/
Mean ct/min
blank
x 100
5RCr-release assay
Details of this procedure, using 1(562 cells
as targets, have been published previously
(Potter & Moore, 1978). Briefly, 51Cr-labelled
target cells were incubated overnight with the
various effector-cell preparations (total
volume 04 ml) and in each case lysis was
calculated from the extent of51Cr release into
the culture supernatants relative to that re-
maining in the cell pellets. In all tests control
tubes with target cells alone were included to
give the background isotope release, and
maximum release was determined by addition
of Triton X100 (1/100 dilution).
Percentage 51Cr release was then calcu-
lated from the formula:
0 51Cr release= S + x 100
where S=ct/min of 0-2 ml supernatant
P ct/min of 0-2 ml supernatant-+-pellet.
Specific chromium release (SCR) in each test
wNas then calculated from the formula:
Te S SCR=T0 x 100
wvhere Te= 0 51Cr release in presence of
effector cells. Te==0/ 51Cr release in presence
of Triton X-100. S=0 spontaneous 5ICr
release oftarget cells alone.
RESULTS
Separation of tumour-infiltrating lympho-
cytes (TIL) from suspensions of enzyme-
disaggregated Mc4OA
Passage of disaggregated tumour sus-
pensions through Sephadex G-10 columns
produced a 3-fold increase in the propor-
tion oflymphocytes to the extentthat they
constituted 5000 of the eluted popula-
tion. The proportion of lymphocytes ex-
ceeded 90%0 of the eluate after passage
through a second identical column. Eighty-
four per cent of this population were
stained with ATS by immunofluorescence.
These cells represented an overall 30%0
recovery of those present in the original
suspension. EA-RFC accounted for 3± 1 0
of cells in the second eluate and tumour
cells, 5±3%0. The differential composition
of 14 independent separations is given in
Table I.
Cytotoxicity of normal lymphocytes against
tumour-derived targets
Before the search for tumour-related
cytotoxicity, the activity of lymphocytes
as a function of anatomical distribution in
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TABLE I.-Differential composition ofSeph-
adex G-10 eluates of enzyme-disaggregated
Mc4OA tumour-cell suspensions
a significant reduction (by 46±9%) in
cytotoxic potential (P<0005 by Student's
t test).
Mean No. cells*
(%±s.e.)
92-0±2-6
84-0±4-2**
1-7± 1-6
0-8±0-8
0-6 0-8
0 4±0 5
4-7±2-7
* Based on 14 independent separations.
** Determined by immunofluorescent staining
with rabbit anti-rat-thymocyte serum (Moore &
Moore, 1977a).
Differential counts were made on Jenner-Giemsa-
stained cytocentrifuge films prepared from cell
suspensions incubated with polystyrene latex for
45 min at 37°C before centrifugation.
the normal host was simultaneously exam-
ined against several tumour targets using
the 75Se assay (Table II). The effect of
lymph node lymphocytes (axillary and
cervical) was frequently growth-stimu-
latory (denoted by negative cytotoxicity
indices) except in the case of Mc4OA,
against which they were minimally cyto-
toxic. The susceptibility of this tumour
target to splenic lymphocytes was also
significantly greater than that ofthe other
targets, against which cytotoxicity was
only occasionally demonstrable. However,
treatment of normal spleen cells by the
Sephadex G-10 procedure for isolating
TIL markedly reduced their cytotoxicity
against Mc4OA targets. Thus, in a series
of 7 experiments their pre-column cyto-
toxicity fell from 59±6 to 27±5% after
passage over Sephadex G-10, representing
Cytotoxicity of lymphocytes of tumour-
bearing rats against tumour-derived targets
The anti-tumour activity of lymphoid
tissues was compared with that of TIL
over a period of 28 days after trocar im-
plantation ofMc4OA. The minority (<5%)
of tumour cells invariably present in TIL
preparations did not appear to interfere
with the 75Se assay. These cells failed to
persist under the culture conditions so as
to be identified visually in washed and
stained microplate wells, and there was no
significant increase in incorporation of
75Se methionine in wells containing TIL
alone, compared with lymphnode or
splenic lymphocytes.
During this period of tumour growth no
consistent cytotoxicity against Mc4OA or
Mc57 target cells in excess of 10% of
normal reactivity could be detected in
tumour-draining axillary lymphnode or
cervical lymph node lymphocytes. In
contrast, on Days 15, 22 and 28, spleen
cells from tumour bearers showed a con-
sistent but lowlevel ofcytotoxicity against
Mc4OAtarget cells of16±3%, 20±2% and
19+6% in excess of normal spleen-cell
cytotoxicity, respectively. No comparable
cytotoxicity was observed against Mc57
targets (data not shown).
The excess cytotoxicity demonstrable
against Mc4OA cells, which was most
probably mediated by lymphocytes since
the spleen-cell preparation had been vir-
TABLE II.-Cytotoxic and stimulatory properties of lymphocytes from normal W/Not rats
against cultured tumour targets estimated by post-labelling with 75Se-methionine
Source of
lymphocytes
Spleen
Cervical LN
Axillary LN
Tumour targets
Mc4OA Mc57 SP22 AAF57
58±5 (13) 5±7 (8) 9±9 (4) -11±11 (4)
14±3 (12) -33±4 (8) -13±4 (4) -25±8 (3)
13±3 (8) -28±11 (6) NT NT
Figures shown are cytotoxicity indices (±s.e.), calculated with respect to control targets incubated in the
absence of lymphocytes. Negative values denote growth stimulation. Number of determinations against
each target are in parentheses.
All lymphocyte preparations were depleted of adherent cells and used at a constant E :T ratio of 100:1.
NT =not tested.
Total lymphocytes
ATS-stained
lymphocytes
Macrophages
Neutrophils
Eosinophils
Basophils
Tumour cells
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tually depleted of macrophages by adher-
ence before test (differential* count:
lymphocytes, 95 8±0.4%; macrophages
0 9I40 2%; polymorphs 2 9±0 3% and
eosinophils, 04±0'2%) was abrogated by
passage ofthe effector cells over Sephadex
G-10, when reactivity returned to the level
of that of normal untreated spleen cells.
Even so, this still represented a real
increase in activity over that of normal
spleen cells, since Sephadex G-10 passagre
of the latter produced further significant
diminution in cytotoxicity (vide supra).
By Day 11, tumours were large enough
to permit extraction of TIL from a pool of
2, and by Day 15 from 1 only. Since there
is no satisfactory source of control lym-
phocytes in the normal host, the cyto-
toxicity ofTIL was compared with that of
normal spleen cells in each test. Consider-
able variation in the susceptibility of
Mc40A and Mc57 targets to lysis by both
spleen cells and TIL was encountered in
these experiments. Neither effector popu-
lation was consistently more active than
the other and generally cytotoxicity was
comparable (Table III). The level of
TIL-mediated cytotoxicity was indepen-
dent of tumour size and time from
implantation. Thus cytotoxicity was com-
parable when tested on Days 11, 15, 22
and 28.
To examine further the specificity of
the cytotoxicity of TIL, cross tests were
performed using TIL from Mc57, in
TABLE III.-Cytotoxicity ofspleen cells and
tumour-infiltrating lymphocytes (TIL)
derived from Mc4OA and Mc57 against
the respective targets estimated by the 75Se
assay
Effector cells
Normal splenic
lymphocytes (8)
Mc4OA TIL (8)
Mc57 TIL (4)
/o Cytotoxicity
(±s.e.)
vs Mc4OA vs Mc57
64±6 17±15
60±8 23±9
53±10 15+19
E: T ratio 100: 1, in all instances.
Numbers of determinations are in parentheses.
addition to Mc4OA. The reactivity ofthese
populations was virtually identical, i.e.
high against Mc4OA and low against
Mc57 (Table III).
The high degree of apparently non-
specific reactivity in TIL and spleen cells
against tumour-derived targets using the
75Se assay, and the absence of comparable
activity in lymph nodes, suggested that
many ofthe cytotoxic phenomenareported
hitherto were attributable to natural
killer (NK) cells.
Cytotoxicity of lymphocytes from normal
and tumour-bearing rats against the human
myeloid cell line, K562
The human myeloid cell line (K562) was
used to monitor NK activity on account
of its susceptibility to the spontaneous
cytotoxic activity ofnormal lymphoid cell
populations of several species, including
the rat (Oehler et al., 1978a; Potter &
Moore, 1978).
The distribution of NK activity in the
lymphoid tissues of normal W/Not rats
was as previously reported from this
laboratory (Potter & Moore, 1978), i.e.
spleen cells possessed high NK activity
whilst that of lymph nodes was uniformly
low. Moreover, in the present study, no
significant departure from this pattern of
reactivity was seen in the lymphoid tissues
of tumour-bearing rats (Fig. 1).
The reactivity of the TIL population,
isolated from a 20-day Mc4OA implant,
was lower than that of normal spleen
(Fig. 1) and closely similar data were
obtained from replicate experiments upon
tumours obtained at 15 and 21 days. The
possibility that this was the consequence
of selective removal of NK cells by the
TIL separation procedure was excluded
by the demonstration that passage ofboth
normal and tumour-bearing spleen-cell
populations over Sephadex G-10 sig-
nificantly enhanced rather than depressed
NK activity. Thus, untreated spleen-cell
populations mediated 30±2% specific
51Cr release (SCR) using K562 as target
cells whereas theeluted cellfraction media-
ted SCR of 41+3% (mean±s.e. of 7
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Fio. 1. Natural killer (NK) activity of
lymphocytes from a normal aind a Mc4OA
tumour-bearing rat estimated by 51Cr
release from K562 target cells.
The tumour-bearing rat was killecl 20
(lays after trocar implantation. All pre-
parations from lymphoid tissues were
depleted of adlherent cells.
Tumour-infiltrating lymphocytes (TIL)
0 O; tumour-bearer spleen, 7 o;
tumour-bearer spleen after passage over
Sephadex G-10, A A; tumour-bearer
axillary lymph nodes, O --- Oi; normal
spleen, * *; normal spleen after pass-
age over Sephadex G-10, A A; and
normal axillary lymph nodes, * --- M.
different spleen-cell preparations). This
increase was significant (P<0 05) by
Student's t test. Furthermore, treatment of
normal spleen cells with the tumour-
disaggregating enzyme mixture (PCD)
for 1 h at room temperature did not sig-
nificantly alter their NK activity.
Comparison of the TIL NK activity
with the differential counts of individual
TIL preparations suggested that the re-
duced activity of TIL in relation to nor-
mal splenic lymphocytes might be a
function of contaminating tumour cells
(Table IV). The effect of adding cultured
Mc4OA cells to the NK system comprising
normal spleen cells and K562 targets was
thus quantitated. A dose-response rela-
tionship emerged which indicated that
inhibition of SCR from K562 cells was
detectable at ratios of Mc4OA: K562 of
less than 1:1 (Fig. 2). From this it was
apparent that contamination of TIL pre-
parations with tumour cells in excess of
200 would cause dose-dependent inhibi-
tion of NK activity.
On the assumption that an uncon-
taminated TIL population might possess
similar reactivity to normal spleen cells,
as was found in the 75Se assay where con-
taminating tumour cells did not appar-
ently interfere, Fig. 2 could be used to
calculate the inhibition that might be
expected in a given TIL preparation con-
taining an estimated number of tumour-
cell contaminants. This exercise is shown
in Table IV where the predicted and actual
decreases in SCR correlate relatively well,
given the limitations inherent in the mor-
phological identification of tumour cells
in stained cytocentrifuge preparations.
Formalin fixation of Mc4OA cells vir-
tually abolished their capacity to inhibit
lysis of K562, even at high ratios (10:1).
TABLE IV. Comparison of natural killer (NVK) reactivity against K562 of normal spleen
cells and TIL*
0/, 5 Cr release
mediated by:
pleen
cells TIL
30 14
24 20
32 26
29 <1
II Actual
(lecrease
in 51Cr
release
J4 M(0)
54
15
21
99
Predicted
(lecrease
in 51Cr
release
(0)t
51
20
38
56
Differential cell composition of TIL§
Tumour Mono- Poly-
TIL cells cytes morphs Other
90 5 2 2 1
94 1 3 2 3
94 2 3 0 1
88 9 1 1 1
* Constant E:T ratio, 50: 1.
t Specific 51Cr release mediated by spleen cells -% specific 51Cr release mediated by TIL x 100
% specific 51Cr release mediated by spleen cells
I Calculated from Fig. 2.
§ Differential counts were made on Jenner-Giemsa-stained cytocentrifuge films prepared from cell
suspension incubated with polystyrene latex for 45 min at 37 C before centrifugation.
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Ratio of unlabelled Mc4O A: K562 cells
FiG. 2.- Effect of viable an(d formalin-fixecl unlabelled Mc4OA cells on natural killer (NK) activity of
normal rat spleen against, K562 targets. Viable Mlc4OA cells, O (Mean of 4 experiments
j( s.e.); foimalin-fixe( Mc4(A cells, x x, O --- O an(d x x (3 separate experiments).
These data indicate that inhibition is not
a passive phenomenon caused simply by
steric hindrance.
DISCUSSION
In the assessment of anti-tumour lym-
phocyte reactivity in situ, the recovery of
viable and functionally active lympho-
cytes essentially free from other cellular
contaminants is obligatory. In this study
Sephadex G-l10 column fractionation was
employed, using the method originally
.described by Ly & Mishell (1974) for
separation of antibody-forming cells from
immune spleen-cell populations. The tech-
nique was modified in that nylon wool was
uised to support the Sephadex instead of
glass beads. The original method has been
dlemonstrated to remove adherent phago-
cytic cells (Pollack et al., 1976) and tumour
cells (Hansen et al., 1977), and to yield an
almost exclusively lymphocytic eluate re-
taining the functional attributes of T
lymphocytes, K and NK cells (Wolfe et al.,
1977). The purity ofthe eluates originating
from the disaggregated Mc4OA suspen-
sions was essentially similar to the MSV
system (Gillespie et al., 1977) provided
that 2 columns were used in sequence.
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Even with this proviso, a small degree of
tumour-cell contamination was unavoid-
able. However, probably the greatest
limitation was the recovery which amoun-
ted to only 30%o of the pre-fractionation
population. The adventitious removal of
cells of potential importance in cytotoxic
reactions is thus a possibility which must
be considered in the interpretation of our
data.
The use ofdifferent assays for the analy-
sis of tumour-related and non-specific
effector functions was necessitated by
several considerations. Preliminary efforts
to establish a short-term 51Cr-release assay
using Mc4OA targets were effectively
thwarted by the unpredictable extent of
spontaneous isotopic release (28-60% over
18 h), an experience not encountered with
the K562 targets used to monitor NK
function. Moreover, although cytolysis
could be detected in normal spleen-cell
populations (Potter & Moore, 1978), in-
creased cytotoxicity in the lymphoid
tissues of tumour-bearers compared with
those from normal controls could not be
unequivocally established. In these cir-
cumstances tumour-related activity was
souight by the 75Se assay.
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This assay was adopted because of the
greater sensitivity of longer-term assays,
which detect both cytolytic and cytostatic
effects. An important finding was that
after 48 h it was impossible to identify the
tumour cells which had initially con-
taminated the TIL preparations. This
could be interpreted in 2 ways: either
effete tumour cells, damaged by the isola-
tion procedure, died early in the assay and
did not interfere with the cytotoxic acti-
vity of lymphocytes in the long term, or
they were initially present in a viable state
and were subsequently killed by the pre-
sence of effector cells in the TIL prepara-
tion (Berczi et al., 1973). Under the latter
circumstances tumour cells might have
competitively inhibited the cytolysis of
target cells, as has been demonstrated in
short-term assays (Gillespie et al., 1977).
However, if competitive inhibition had
been significant in the longer-term 75Se
assay, the effect must havebeen fortuitous,
because each time a TIL population was
tested the level of cytotoxicity was
comparable with that of normal splenic
lymphocytes, regardless of the degree of
tumour-cell contamination and of the
tumour of origin of the TIL. Thus, by
contrast with the 5ICr assay against K562
targets (discussed below), it is improbable
that competitive inhibition is a major
complicating factor in the interpretation
of our 75Se data.
Use of the 75Se assay demonstrated the
importance of investigating the relative
susceptibility of target cell lines to the
cytotoxic effect of lymphoid cells. Thus
the results from testing effector cells
isolated from the tumour and lymphoid
tissue of Mc4OA tumour-bearing animals
against a range of antigenically distinct
tumour target cells could be interpreted
as indicating a degree of tumour-specific
cytotoxicity. However, the reality of the
situation was only revealed when (a)
effector cells from normal lymphoid tissue
were tested and (b) crossover experiments
were performed using TIL isolated from an
antigenically distinct sarcoma. These data
indicated that target-cell susceptibility,
ratherthan antigenic specificity, influenced
the outcome ofthe cytotoxicity assays.
The anatomical distribution of cyto-
toxic effector cells and the differential
susceptibility of target cells detected by
the 758e assay suggested that the effector
cell in populations derived from Mc4OA
tumour-bearers was comprised, in part if
not wholly, ofNK cells. Thiswas confirmed
by the lytic activity of the preparations
against the xenogeneic K562 target cells.
However, an adherent cell also appeared
to be active in the 75Se assay, since
Sephadex C4-10 filtration reduced the
cytotoxicity of both normal and tumour-
bearer spleen-cell populations. This cell,
putatively a macrophage, may have been
similar to the phagocytic, non-specifically
cytostatic cell type identified in the spleens
of tumour-bearing mice (Mantovani et al.,
1977). In that study the presence of tu-
mour was a prerequisite for demonstration
of this activity, in contrast to the present
findings, where it was also detected in
normal spleen. Such a cell, being cyto-
static as opposed to cytolytic, would not
be expected to be involved in a 5ICr-
release assay, and this was shown to be the
case because Sephadex G-10 filtration of
spleen cells enhanced 51(Cr release from
K562 cells, presumably by removal of
irrelevant cells from the effector popula-
tion.
WVhile Sephadex G(-10 treatment re-
duced the cytotoxicity ofboth normal and
tumour-bearer spleens in the 75Se assay,
the latter remained persistently more
cytotoxic than the former. This suggests
that a third cell type may be involved in
mediating the enhanced cytotoxicity of
tumour-bearer spleen cells between Days
15 and 28 of tumour growth. In so far as
Sephadex G-10 eluates consist predomin-
antly of T-lymphocytes, and comparable
cytotoxicity could not be demonstrated
against an antigenically unrelated target
(Mc57), the data are consistent with a
tumour-related (? specific) component in
addition to the NK element. However,
this interpretation must be considered
with the awareness that Mc57 targets are
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less susceptible than Mc4OA to NK cells.
The close correspondence between the
activity of TIL and of normal spleen cells,
and their lack of target-cell specificity in
the 75Se assay, implied that the pre-
dominant effector function in both popula-
tions is mediated by NK cells. The finding
that the activity of TIL against K562 was
lower than that of tumour-bearer spleen
cells was thus somewhat unexpected, par-
ticularly as the Sephadex C(-10 procedure
produced a modest but significant increase
in activity. An alternative possibility that
the low levels of cytotoxicity mediated by
TIL might be a consequence of non-
specific activation during the separation
procedure of an otherwise non-eytotoxic
population seems unlikely, but cannot be
easily dismissed (WVardley et al., 1976). To
do so would require the use of other tech-
niques for the separation of TIL (e.g.
density-gradient separation) which to date
have proved unsatisfactory.
The essence ofthe phenomenon was dis-
closed by the inverse relationship between
tumour cell contaminants in the TIL
population and the level of cytotoxicity
relative to that of normal spleen cells.
This was confirmed by experiments in
which the presence of third-party Mc4OA
cells caused a dose-dependent decrease in
NK activitv. It has been shown pre-
viously (Potter & Moore, 1978) that Mc4OA
cells are susceptible to NK effects, so that
the phenomenon here described is one of
cold inhibition, an interpretation suppor-
ted by the failure of fixed Mc4OA cells to
achieve the same effect. In our experience,
interference by contaminating tumour
cells was thus a more pervasive problem in
the short-term cytolvtic test than in the
longer-term 75Se assay. Our data indicate
that if it had been possible to prepare
TIL in which tumour-cell contamination
was <20%, their activity would have been
at least equal to that of either normal or
tumour-bearer spleen cells, estimated by
51C)r release.
In the rat, as in other species, NK cells
are characterized by operational criteria.
Althoughi association with a minority
population within the TIL compartment
cannot be excluded, it is likely that the
effectors belong to the predominant popu-
lation which stains with ATS. Antisera
prepared by conventional procedures, like
our reagent, have been shown to react
with NK cells (Shellam, 1977). Such reac-
tivity is removed by an additional absorp-
tion step using spleen cells from thym-
ectomized, irradiated and marrow-recon-
stituted rats, which leaves anti-T-cell
activity intact. Whether the presence of
NK cells within tumours has an immuno-
logical basis cannot be determined, since
little is known at present of the relation-
ship between NK function and conven-
tional immune responses.
It has been postulated that NK cells
may play a role in the immune surveillance
of tumours (Herberman & Holden, 1978).
Recent observations that NK activity is
strongly augmented in vivo by injection of
agents with potent anti-tumour properties
such as BCG, C. parrum and poly-IC are
consistent with this hypothesis (Tracey
et al., 1977; Wolfe et al., 1977; Oehler
et al., 1978b).
However, macrophages also comprise a
significant proportion of the infiltrating
cells which can be separated from de-
veloping tumours (Moore & Moore, 1977b);
moreover, these cells are functionally
active and inhibit the growth of tumour
cells as assessed by the 75Se assay (Moore
& Moore, 1979). A role for the macrophage
in the regulation of NK activity at a sys-
temic level has been suggested (Oehler &
Herberman, 1978) butwhetheranyrelation-
ship exists at the tumour site is unknown.
Theappearance ofvarioushost-cellpopula-
tions in tumours strongly suggests that the
actual events in vivo are dependent upon
precisely controlled relationships between
the infiltrating cell types. Probably in no
situation is this more apparent than the
MSV tumour-host system, where the cyto-
lytic activity of both intra-tumour T
lymphocytes (fHolden et al., 1976; Gillespie
et al., 1977; Plata & Sordat, 1977) and
macrophages (Russell et al., 1977; Russell
& McIntosh, 1977) varies with the growth
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status ofneoplasms. For instance, specific-
ally cytotoxic T cells can be isolated from
both regressors and progressors, but in the
latter only during the early stages of
tumour growth (Gillespie et al., 1977).
Although cytotoxicity data were un-
attainable before Day 11 of the growth of
Mc4OA, this system is analogous tothatof
MSV, in so far as no specifically cytotoxic
T cells could be detected in TIL isolated
from progressive tumours. Yet there is
little doubt that thymus-derived lympho-
cytes are ofprimary importance in tumour
recognition and rejection, as indicated by
the specificity of in vivo rejection of small
inocula in pre-immunized hosts. However,
the vast majority of T lymphocytes pre-
sumably enter an established tumour
indiscriminately, while only a small pro-
portion may be sensitized to the eliciting
antigen and accumulate preferentially.
Also their cytotoxic efficiency may be
suppressed by factors at a local and/or
systemic level.
This work was supported by grants from the
Medical Research Council and the Cancer Research
Campaign.
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